BiotechTube
Home/Sidewinder Therapeutics/Carl Gordon, Ph.D., C.F.A.
CG

Carl Gordon, Ph.D., C.F.A.

Chairman of the Board

Sidewinder Therapeutics

Therapeutic Areas

OncologyRare Diseases

Sidewinder Therapeutics Pipeline

DrugIndicationPhase
Undisclosed Bispecific ADC ProgramsOncology and Rare DiseasesPre-clinical

Leadership Team at Sidewinder Therapeutics

EM
Eric Murphy, Ph.D.
Chief Executive Officer, Co-Founder & Director
RM
Rob McRae
President & Chief Operating Officer
MM
Michael Mueller
General Counsel
RC
Ryan Corcoran, M.D., Ph.D.
Co-Founder & Director
View full Sidewinder Therapeutics profile